Belgrade BPH Masterclass okupio je u Beogradu 150 učesnika iz 14 zemalja kako bi razmotrili savremene mogućnosti lečenja benignog uvećanja prostate.

A consortium of private healthcare firms is set to inaugurate Nigeria’s first 160-watt holmium laser system for the treatment ...

Zasilkovna founder Simona Kijonkova has invested tens of millions of crowns in Andromeda Surgical, a US startup building an ...

Agarwal presented the TALAPRO-3 results at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. Agarwal ...

The FDA cleared the SpaceOAR Flex System, a hydrogel spacer used during prostate cancer radiotherapy, in a 510 (k) supported by the HYDROSPACE trial.

Men with high-risk prostate cancer have a higher likelihood of residual disease after prostatectomy and may require radiation ...

A recent analysis of the NRG-RTOG 0534 "SPPORT" clinical trial evaluated the Luminal B (LumB) molecular subtype using the ...

Men with high-risk prostate cancer have a higher likelihood of having residual disease following prostatectomy and may require radiation therapy after surgery, particularly when PSA levels begin to ...

When David Brown learned he had prostate cancer at 48, survival was not his only concern. A husband, father, and businessman, he wanted to understand how treatment could control his cancer and affect ...

Learn how prostate cancer is treated at each stage, from active surveillance and surgery to radiation, hormone therapy, and targeted drugs.

Holmium/thulium laser enucleation of the prostate (LEP) is an established, size-independent surgical option for benign prostatic hyperplasia, while Aquablation is an emerging robotic waterjet therapy.